Table 1 Clinical features of patients infected with HAdV-55 or HAdV-7 in this study

Age (yrs)

0.73 ± 0.78

2.48 ± 3.06

0.120

Male (%)

5/8 (63%)

26/32 (81%)

0.256

Any underlying diseases

0

2/32

0.529

 Fever≥38 °C

7/7 ^a (100%)

32/32 (100%)

/

 Maximum temperature (°C)

39.41 ± 0.94^b

39.79 ± 0.64

0.161

 Duration of fever (days)

14.5 ± 10.75^b

15.14 ± 5.48

0.960

 Cough

6/6^b (100%)

32/32 (100%)

/

 Rhinorrhea

2/6^b (33%)

4/32 (13%)

0.199

 Wheezing

1/6^b (17%)

20/32 (63%)

0.038^c

 Swelling of tonsils

4/6^b (67%)

13/32 (41%)

0.239

 Rash

2/6^b (33%)

5/32 (16%)

0.305

 Vomiting

0^b

3/32 (9%)

0.435

 Diarrhea

1/6^b (17%)

11/32 (34%)

0.392

 Dyspnea

2/6^b (33%)

10/32 (31%)

0.920

 Lung infiltrates

4/6^b (67%)

16/32 (50%)

0.453

 Complication^d

2/7^a (29%)

18/32 (56%)

0.184

 WBC (10⁹/L)

11.48 ± 3.08^a

10.64 ± 5.71

0.709

 Neutrophil %

63.20% ± 15.03%^a

57.98% ± 17.46%

0.469

 Lymphocyte %

29.26% ± 12.53%^a

35.25% ± 17.59%

0.402

 Platelet (10⁹/L)

274.71 ± 184.61^a

291.29 ± 146.87

0.801

 CRP (mg/L)

26.53 ± 24.84^a

33.42 ± 45.86

0.706

 ICU admission

1/7^a (14%)

5/32 (16%)

0.929

 Mechanical ventilation

1/6^b (17%)

9/32 (28%)

0.559

 Immunoglobulin

2/7^a (29%)

17/32 (53%)

0.239

 Length of hospital stay (days)

11.33 ± 6.86^b

19.10 ± 10.41

0.109

 Clinical score^e

6.43 ± 2.44^a

8.21 ± 2.98

0.148